# FDA 483 - MACSEN DRUGS - September 01, 2023

Source: https://www.keypedia.com/records/483/macsen-drugs/d07412cd-f349-4873-92ef-a979b8e3bbde

> FDA 483 for MACSEN DRUGS on September 01, 2023. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: MACSEN DRUGS
- Inspection Date: 2023-09-01
- Product Type: other
- Office Name: Office of Human and Animal Food Operations
- Summary: During an FDA inspection from August 21 to September 1, 2023, Nutraceutical Corporation, a dietary supplement manufacturer in Park City, UT, received a Form FDA 483 listing significant observations related to its manufacturing and quality control processes. The inspection highlighted several departures from current Good Manufacturing Practices for dietary supplements.
A primary concern was the company's failure to establish adequate specifications for components, including not verifying the identity of raw materials like Cellulose and Fenugreek Seed Powder through scientifically valid methods. This was a repeat observation regarding component identity from previous inspections. Furthermore, Quality Control operations were found deficient, as personnel did not ensure identity and strength testing for dietary ingredients or finished products, and in some cases, released products (e.g., Solaray Vitamin D-3, Solaray Zinc) that failed internal specifications.
The company's Master Manufacturing Records were incomplete, lacking essential information on in-process and finished batch testing, as well as corrective action plans for when specifications were not met. Lastly, Nutraceutical Corporation lacked proper written procedures for holding finished dietary supplements, specifically regarding environmental conditions like temperature and humidity, despite observing high temperatures in the warehouse. These observations indicate a need for comprehensive corrective actions to ensure compliance with federal regulations for dietary supplement manufacturing.

## Related Documents

- [483 - 2023-01-25](https://www.keypedia.com/records/483/macsen-drugs/b590c2b5-f366-4915-83fb-afa05c5f9891)
- [483 - 2024-09-06](https://www.keypedia.com/records/483/macsen-drugs/54265066-d37e-4490-a3b2-a10d774e5828)
- [483 - 2024-09-06](https://www.keypedia.com/records/483/macsen-drugs/7aec2348-bffd-437e-b000-eec912c99cb5)
- [483 - 2024-09-06](https://www.keypedia.com/records/483/macsen-drugs/e7e0f9cd-9800-4857-8c33-26a40e69ee0a)

## Related Officers

- [Jose E. Almeida](https://www.keypedia.com/people/jose-e-almeida/1df7930c-d835-4c16-85a0-4c9adbb531a4)
- [Phillip C. Trefsgar](https://www.keypedia.com/people/phillip-c-trefsgar/8034282c-6b16-46e7-9a56-dbe32e0b99dd)
- [Professor of Medicine](https://www.keypedia.com/people/lawrence-r-deyton/92881ee2-c62d-4faf-b619-4900022cc779)

Company: https://www.keypedia.com/companies/macsen-drugs/d566779f-f5f3-4d75-8cd2-ca281c31c4c9

Office: https://www.keypedia.com/offices/office-of-human-and-animal-food-operations/cf23dae6-1323-4680-9a7e-ac4ee8c3c287